HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹908 Cr | ₹851 Cr | ₹799 Cr | ₹655 Cr | ₹545 Cr |
What is the latest Appropriations of HIKAL ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹908 Cr |
| Mar2024 | ₹851 Cr |
| Mar2023 | ₹799 Cr |
| Mar2022 | ₹655 Cr |
| Mar2021 | ₹545 Cr |
How is Appropriations of HIKAL Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹908 Cr | 6.66 | |
| Mar2024 | ₹851 Cr | 6.56 | |
| Mar2023 | ₹799 Cr | 22.04 | |
| Mar2022 | ₹655 Cr | 20.03 | |
| Mar2021 | ₹545 Cr | - | |
Compare Appropriations of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,964.1 Cr | -0.5% | -5.4% | -33.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.5% |
-5.4% |
-33.2% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses